Results 31 to 40 of about 2,681,651 (342)

Establishment and Functional Characterization of Murine Monoclonal Antibodies Recognizing Neuritin

open access: yesAntibodies, 2023
Neuritin represents a neurotrophic factor that is not only important in neuronal development and plasticity but also impacts endothelial angiogenesis, cell migration, tumor growth and the production of antibodies by B cells.
Georgia Papadogianni   +6 more
doaj   +1 more source

Rat Monoclonal Antibodies Specific for LST1 Proteins [PDF]

open access: yes, 2009
The LST1 gene is located in the human MHC class III region and encodes transmembrane and soluble isoforms that have been suggested to play a role in the regulation of the immune response and are associated with inflammatory diseases such as rheumatoid ...
Kremmer, Elisabeth   +4 more
core   +1 more source

Production and characterization of polyclonal antibody against a synthetic peptide from β-actin protein [PDF]

open access: yesIranian Journal of Basic Medical Sciences, 2014
Objective(s):Antibodies against actin, as one of the most widely studied structural and multifunctional housekeeping proteins in eukaryotic cells, are used as internal loading controls in western blot analyses.
Nazila Amini   +6 more
doaj  

Production of two SARS-CoV-2 neutralizing antibodies with different potencies in Nicotiana benthamiana

open access: yesFrontiers in Plant Science, 2022
Monoclonal antibodies are considered to be highly effective therapeutic tools for the treatment of mild to moderate COVID-19 patients. In the present work, we describe the production of two SARS-CoV-2 human IgG1 monoclonal antibodies recognizing the ...
Rachele Frigerio   +12 more
doaj   +1 more source

Tumor necrosis factor inhibitors in psoriatic arthritis. [PDF]

open access: yes, 2017
INTRODUCTION: Psoriatic arthritis (PsA) is a chronic inflammatory disease that can result in significant disability. With the emergence of tumor necrosis factor inhibitors (TNFi), therapeutic outcomes in PsA have improved substantially.
Kraft, Walter K.   +2 more
core   +2 more sources

Save the microbes to save the planet. A call to action of the International Union of the Microbiological Societies (IUMS)

open access: yesOne Health Outlook, 2023
Our planet is populated by at least a trillion species of microorganisms. Every life form is sustained by them and they make the planet habitable. Only a minority of them, about 1400 species, cause infectious diseases that are responsible for human ...
Rino Rappuoli   +4 more
doaj   +1 more source

Lentil lectin derived from Lens culinaris exhibit broad antiviral activities against SARS-CoV-2 variants

open access: yesEmerging Microbes and Infections, 2021
The spike (S) protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutated continuously and newly emerging variants escape from antibody-mediated neutralization raised great concern.
Wenbo Wang   +11 more
doaj   +1 more source

Junctional Adhesion Molecule-C Mediates the Recruitment of Embryonic-Endothelial Progenitor Cells to the Perivascular Niche during Tumor Angiogenesis [PDF]

open access: yes, 2020
The homing of Endothelial Progenitor Cells (EPCs) to tumor angiogenic sites has been described as a multistep process, involving adhesion, migration, incorporation and sprouting, for which the underlying molecular and cellular mechanisms are yet to be ...
Bieback, Karen   +6 more
core   +1 more source

Past, Present, and Future of Rituximab—The World’s First Oncology Monoclonal Antibody Therapy

open access: yesFrontiers in Oncology, 2018
Rituximab is a chimeric mouse/human monoclonal antibody (mAb) therapy with binding specificity to CD20. It was the first therapeutic antibody approved for oncology patients and was the top-selling oncology drug for nearly a decade with sales reaching $8 ...
Timothy M. Pierpont   +2 more
semanticscholar   +1 more source

Safety and serum distribution of anti-SARS-CoV-2 monoclonal antibody MAD0004J08 after intramuscular injection

open access: yesNature Communications, 2022
Monoclonal antibodies (mAbs) are a potential therapeutic option for treatment of COVID-19. Here, the authors report safety and pharmacokinetics of an intramuscularly injected mAb (MAD0004J08) during the first 30 days of a phase 1 clinical study.
Simone Lanini   +21 more
doaj   +1 more source

Home - About - Disclaimer - Privacy